Clinical Trials
3 results for Prostate Cancer
An Open-label, Single Arm, Roll-over Study to Provide Continued Treatment With Darolutamide in Participants Who Were Enrolled in Previous Bayer Sponsored Studies
- Condition: Cancer
- Study ID: NCT04464226
A Single-arm, Open-label Phase 4 Study of Darolutamide in Addition to Standard Androgen Deprivation Therapy for Participants in India With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
- Condition: Non-metastatic Castration-resistant Prostate Cancer
- Study ID: NCT05348876
A Randomized, Double-blind, Placebo-controlled Phase 2 Study of Darolutamide Versus Placebo in Addition to Standard Androgen Deprivation Therapy for Participants With High-risk Non-metastatic Castration Resistant Prostate Cancer (nmCRPC)
- Condition: Prostate Cancer
- Study ID: NCT05171387